BR100 Decreased By (-0.54%)
BR30 Decreased By (-0.74%)
KSE100 Decreased By (-0.42%)
KSE30 Decreased By (-0.37%)
AGHA 6.62 Decreased By ▼ -0.05 (-0.75%)
BECO 4.39 Increased By ▲ 0.04 (0.92%)
BML 54.95 Decreased By ▼ -1.22 (-2.17%)
BOP 29.93 Decreased By ▼ -0.19 (-0.63%)
CNERGY 12.80 Decreased By ▼ -0.18 (-1.39%)
CSIL 5.20 Decreased By ▼ -0.11 (-2.07%)
FCCL 51.18 Decreased By ▼ -0.47 (-0.91%)
FFL 14.40 Decreased By ▼ -0.09 (-0.62%)
FNEL 1.23 Increased By ▲ 0.02 (1.65%)
KEL 6.03 Decreased By ▼ -0.03 (-0.5%)
KOSM 5.60 Decreased By ▼ -0.24 (-4.11%)
LOTCHEM 26.07 Decreased By ▼ -0.10 (-0.38%)
MLCF 89.90 Decreased By ▼ -1.33 (-1.46%)
NBP 162.53 Decreased By ▼ -1.66 (-1.01%)
NCPL 52.37 Decreased By ▼ -0.81 (-1.52%)
NPL 57.85 Decreased By ▼ -1.27 (-2.15%)
OGDC 313.00 Decreased By ▼ -0.39 (-0.12%)
PACE 9.71 Decreased By ▼ -0.06 (-0.61%)
PAEL 34.90 Decreased By ▼ -0.34 (-0.96%)
PIBTL 14.37 Decreased By ▼ -0.34 (-2.31%)
PPL 219.15 Decreased By ▼ -2.21 (-1%)
PRL 91.60 Increased By ▲ 0.38 (0.42%)
PTC 59.25 Increased By ▲ 0.06 (0.1%)
SSGC 23.37 Increased By ▲ 0.07 (0.3%)
TBL 8.65 Decreased By ▼ -0.10 (-1.14%)
TELE 7.47 Decreased By ▼ -0.14 (-1.84%)
TPL 21.32 Decreased By ▼ -0.71 (-3.22%)
TPLP 12.14 Decreased By ▼ -0.42 (-3.34%)
TREET 21.64 Decreased By ▼ -0.09 (-0.41%)
TRG 55.20 Decreased By ▼ -0.59 (-1.06%)

LAHORE: The Lahore High Court on Thursday sought more arguments on a petition of PTI former chairman Imran Khan challenging the jurisdiction of a trial judge hearing a rupees ten billion defamation suit against him by Prime Minister Shehbaz Sharif.

The court had earlier reserved the verdict on the petition after PTI’s lawyer concluded his arguments.

The court, however, now sought further arguments from the counsel on February 20.

Previously, the petitioner’s counsel had said an additional district & sessions judge had been hearing the defamation case.

He argued that a suit involving a claim of rupees ten billion can be tried by a district judge notified by the LHC chief justice.

Copyright Business Recorder, 2025

Comments

Comments are closed for this article.